Kb. Hart et al., POTENCY FOLLOWING CONFORMAL NEUTRON PHOTON IRRADIATION FOR LOCALIZED PROSTATE-CANCER/, International journal of radiation oncology, biology, physics, 35(5), 1996, pp. 881-884
Citations number
15
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: To assess the effect of conformal neutron/photon irradiation
with or without neoadjuvant hormonal therapy on posttreatment potency.
Materials and Methods: Seventy-six patients with localized adenocarci
noma of the prostate, Stage T1 or T2 N0 M0, Gleason score less than or
equal to 7, were enrolled on a prospective Phase II study, Each patie
nt received 9-10 Neutron + 38 Photon Gy, Twenty-eight patients receive
d neoadjuvant hormonal therapy in conjunction with radiation therapy,
Potency was assessed prior to starting treatment and was assessed at e
ach subsequent follow-up visit. Results: Fifty-two of 75 patients (70%
) were potent at the start of therapy, Thirty-eight of 52 (73%) had fu
nctional erections and 14 of 52 (27%) had erections termed nonfunction
al, which were of insufficient strength for intercourse. After treatme
nt, 35 of 52 (67%) retained potency, Twenty-nine of 38 (76%) with func
tional erections pretreatment maintained this ability, Only 6 of 14 pa
tients (43%) with nonfunctional erection pretreatment maintained their
level of potency, Neoadjuvant hormonal therapy did not impact on the
ability to maintain erections, Sixty-five percent of those patients re
ceiving hormones retained erectile function, while 69% of those who di
d not receive hormones maintained erectile function, Age was not a sig
nificant factor in posttreatment potency, although a trend towards pot
ency in younger patients was observed, (p = 0.74).Conclusion: The majo
rity (67%) of patients maintained their level of erectile function fol
lowing conformal sequential neutron photon irradiation, This is compar
able to that achieved with photon irradiation alone, No significant ch
ange in potency was seen with neoadjuvant hormonal therapy or with inc
reasing patient age.